The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated×3•Originally published 7 April 2026•Updated 8 April 2026•

1 min read

Raymond James Upgrades UnitedHealth to Outperform on AI and Margin Growth

Key Facts

1Raymond James analyst John Ransom upgraded UnitedHealth Group from 'Market Perform' to 'Outperform'.

about 2 months ago

Version History

6 additional sources confirmed this story

Version 3about 2 months ago

What changed: UnitedHealth shares experienced a significant 9.4% price surge on high trading volume, supported by a positive trend in analyst earnings estimate revisions.

Version 2about 2 months ago

What changed: Added technical resistance levels following the $300 breakout and incorporated projections regarding declining Medicare Advantage membership.

Version 1about 2 months ago

What changed: The story was updated to include positive regulatory developments regarding 2027 Medicare Advantage reimbursement rates and management's strategy to restore 13-16% earnings growth despite current cost pressures.

Raymond James analyst John Ransom has upgraded UnitedHealth Group (UNH) to 'Outperform' with a $330 price target, citing AI initiatives and margin optimization. Following the upgrade and positive CMS reimbursement news, UNH shares surged 9.4% in the most recent trading session on above-average volume. Recent trends in earnings estimate revisions further suggest potential for continued strength in the stock price ahead. From a technical perspective, the stock has successfully broken the $300 level, though it faces an identified resistance zone between $300 and $400. Despite the rally, the company faces headwinds from projected membership declines in its Medicare Advantage program. Management still aims for 13-16% long-term earnings growth by 2026-2027, projecting 2026 adjusted EPS exceeding $17.75 on $440 billion in revenue.